• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1458例潜在恶性口腔黏膜疾病患者的恶性转化:一项基于台湾某医院的随访研究。

Malignant transformation in 1458 patients with potentially malignant oral mucosal disorders: a follow-up study based in a Taiwanese hospital.

作者信息

Hsue Shue-Sang, Wang Wen-Chen, Chen Chung-Ho, Lin Cheng-Chung, Chen Yuk-Kwan, Lin Li-Min

机构信息

Department of Oral Pathology, School of Dentistry, College of Dental Medicine, Kaohsiung Medical University, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.

出版信息

J Oral Pathol Med. 2007 Jan;36(1):25-9. doi: 10.1111/j.1600-0714.2006.00491.x.

DOI:10.1111/j.1600-0714.2006.00491.x
PMID:17181738
Abstract

BACKGROUND

It is generally accepted that the development of cancer in the oral mucosa is preceded by an identifiable non-invasive precursor lesion. The aim of this follow-up study was to estimate the rate and the time to transformation in a group of patients from southern Taiwan with potentially malignant oral epithelial lesions.

METHODS

The follow-up time is defined as the duration between the onset of the initial diagnosis and the occurrence of confirmed oral cancer. A total of 1458 patients with histological diagnoses of various pre-malignant oral lesions were followed up between 1991 and 2001. The average age at initial diagnosis was 47.5 years. The histological diagnoses were divided into six categories: epithelial dysplasia with hyperkeratosis/epithelial hyperplasia (8.85%); epithelial dysplasia with submucous fibrosis (2.54%); submucous fibrosis (27.57%); hyperkeratosis/epithelial hyperplasia (29.01%); lichen planus (9.80%) and verrucous hyperplasia (22.22%).

RESULTS

Within the cohort of 1458 patients, 44 patients progressed to oral cancer in the same site as the initial lesions with an overall transformation rate of 3.02% and a mean follow-up time of 42.64 months. Eight of the 166 patients with dysplastic lesions and 15 of 423 patients with hyperkeratosis/epithelial hyperplasia progressed to malignancy. The other patients with malignant transformation originated from various pre-cancerous oral lesions and conditions (submucous fibrosis, eight of 402; lichen planus, three of 143; verrucous hyperplasia, 10 of 324).

CONCLUSION

These results indicate that patients with pre-malignant oral lesions need long-term follow up.

摘要

背景

人们普遍认为,口腔黏膜癌的发生之前会出现可识别的非侵袭性前驱病变。这项随访研究的目的是评估台湾南部一组患有潜在恶性口腔上皮病变患者的病变转变率和转变时间。

方法

随访时间定义为初次诊断开始至确诊口腔癌发生之间的持续时间。1991年至2001年期间,对总共1458例经组织学诊断为各种癌前口腔病变的患者进行了随访。初次诊断时的平均年龄为47.5岁。组织学诊断分为六类:伴有角化过度/上皮增生的上皮发育异常(8.85%);伴有黏膜下纤维化的上皮发育异常(2.54%);黏膜下纤维化(27.57%);角化过度/上皮增生(29.01%);扁平苔藓(9.80%)和疣状增生(22.22%)。

结果

在1458例患者队列中,44例患者在与初始病变相同的部位进展为口腔癌,总体转变率为3.02%,平均随访时间为42.64个月。166例发育异常病变患者中有8例以及423例角化过度/上皮增生患者中有15例进展为恶性肿瘤。其他发生恶性转变的患者源自各种癌前口腔病变和状况(黏膜下纤维化,402例中有8例;扁平苔藓,143例中有3例;疣状增生,324例中有10例)。

结论

这些结果表明,患有癌前口腔病变的患者需要长期随访。

相似文献

1
Malignant transformation in 1458 patients with potentially malignant oral mucosal disorders: a follow-up study based in a Taiwanese hospital.1458例潜在恶性口腔黏膜疾病患者的恶性转化:一项基于台湾某医院的随访研究。
J Oral Pathol Med. 2007 Jan;36(1):25-9. doi: 10.1111/j.1600-0714.2006.00491.x.
2
Malignant transformation in 5071 southern Taiwanese patients with potentially malignant oral mucosal disorders.5071 例台湾南部口腔黏膜潜在恶性疾病患者的恶性转化。
BMC Oral Health. 2014 Aug 5;14:99. doi: 10.1186/1472-6831-14-99.
3
Oral verrucous hyperplasia: histologic classification, prognosis, and clinical implications.口腔疣状增生:组织学分类、预后及临床意义。
J Oral Pathol Med. 2009 Sep;38(8):651-6. doi: 10.1111/j.1600-0714.2009.00790.x. Epub 2009 Jul 27.
4
Factors predicting malignant transformation in oral potentially malignant disorders among patients accrued over a 10-year period in South East England.在英格兰东南部,经过 10 年的时间,有哪些因素可以预测口腔潜在恶性疾病患者的恶性转化。
J Oral Pathol Med. 2011 Oct;40(9):677-83. doi: 10.1111/j.1600-0714.2011.01054.x. Epub 2011 Jul 18.
5
Role of TP53 in the progression of pre-malignant and malignant oral mucosal lesions. A follow-up study of 144 patients.TP53 在口腔黏膜癌前病变和恶性病变进展中的作用。对 144 例患者的随访研究。
J Oral Pathol Med. 2009 Aug;38(7):565-71. doi: 10.1111/j.1600-0714.2009.00766.x.
6
Expression of BUBR1 in human oral potentially malignant disorders and squamous cell carcinoma.BUBR1在人类口腔潜在恶性疾病和鳞状细胞癌中的表达。
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010 Feb;109(2):257-67. doi: 10.1016/j.tripleo.2009.08.014. Epub 2009 Nov 17.
7
[Potentially malignant disorders of the oral mucosa: terminology and classification].[口腔黏膜潜在恶性疾病:术语和分类]
Rev Stomatol Chir Maxillofac. 2010 Sep;111(4):208-12. doi: 10.1016/j.stomax.2010.07.007. Epub 2010 Aug 23.
8
[Precancerous lesions of the buccal mucosa].[口腔黏膜癌前病变]
Rev Stomatol Chir Maxillofac. 2001 Apr;102(2):77-108.
9
Longitudinal study of TP53 mutations in eight patients with potentially malignant oral mucosal disorders.8例潜在恶性口腔黏膜疾病患者TP53基因突变的纵向研究
J Oral Pathol Med. 2009 Oct;38(9):716-21. doi: 10.1111/j.1600-0714.2009.00767.x. Epub 2009 Mar 14.
10
Potentially malignant oral lesions in northern Ireland: a 20-year population-based perspective of malignant transformation.北爱尔兰潜在恶性口腔病变:基于人群的20年恶变视角
Oral Dis. 2001 Jan;7(1):18-24.

引用本文的文献

1
Clinical and histological indicators for malignant transformation of oral submucous fibrosis: an analysis of cases from a tertiary care center.口腔黏膜下纤维化恶变的临床及组织学指标:来自三级医疗中心的病例分析
BMC Oral Health. 2025 Jul 2;25(1):1053. doi: 10.1186/s12903-025-06443-y.
2
Role of demographics, adverse habits and presentation delay on the development of head and neck cancer- A questionnaire based cross sectional study.人口统计学、不良习惯及就诊延迟对头颈部癌症发生的作用——一项基于问卷调查的横断面研究
J Family Med Prim Care. 2025 Apr;14(4):1486-1493. doi: 10.4103/jfmpc.jfmpc_1833_24. Epub 2025 Apr 25.
3
Comparative analysis of blood vessel morphometry in advanced oral submucous fibrosis and malignancy associated with oral submucous fibrosis.
晚期口腔黏膜下纤维化及与口腔黏膜下纤维化相关的恶性肿瘤中血管形态计量学的比较分析。
J Oral Maxillofac Pathol. 2025 Jan-Mar;29(1):12-17. doi: 10.4103/jomfp.jomfp_89_24. Epub 2025 Mar 28.
4
Patterns of Oral and Maxillofacial Lesions in Eastern Uttar Pradesh Region: A Retrospective Study.印度北方邦东部地区口腔颌面病变模式:一项回顾性研究。
J Maxillofac Oral Surg. 2025 Feb;24(1):45-51. doi: 10.1007/s12663-022-01736-z. Epub 2022 May 28.
5
MIAT promotes myofibroblastic activities and transformation in oral submucous fibrosis through sponging the miR-342-3p/SOX6 axis.微小 RNA 转录物 1(MIAT)通过海绵吸附 miR-342-3p/性别决定区 Y 框蛋白 6(SOX6)轴促进口腔黏膜下纤维性变中成纤维细胞的肌成纤维细胞活性和转化。
Aging (Albany NY). 2024 Oct 7;16(19):12909-12927. doi: 10.18632/aging.206121.
6
Role of Antioxidant Vitamins in Oral Submucous Fibrosis: A Narrative Review.抗氧化维生素在口腔黏膜下纤维化中的作用:一篇叙述性综述
Cureus. 2024 May 3;16(5):e59596. doi: 10.7759/cureus.59596. eCollection 2024 May.
7
Identification and Evaluation of Cancer Stem Cells in Oral Squamous Cell Carcinoma and Oral Epithelial Dysplasia Using NANOG: An Immunohistochemical Study.使用NANOG对口腔鳞状细胞癌和口腔上皮发育异常中癌症干细胞的鉴定与评估:一项免疫组织化学研究
Cureus. 2024 Feb 27;16(2):e55111. doi: 10.7759/cureus.55111. eCollection 2024 Feb.
8
An Evidence-Based Update on the Potential for Malignancy of Oral Lichen Planus and Related Conditions: A Systematic Review and Meta-Analysis.口腔扁平苔藓及相关病症恶变可能性的循证更新:一项系统评价与荟萃分析
Cancers (Basel). 2024 Jan 31;16(3):608. doi: 10.3390/cancers16030608.
9
Comparative Study of Injection Triamcinolone and Hyaluronidase Combination with Injection Platelet Rich Plasma (PRP) in Management of Oral Submucous Fibrosis (OSMF).曲安奈德与透明质酸酶联合注射富血小板血浆(PRP)治疗口腔黏膜下纤维化(OSMF)的对比研究
Indian J Otolaryngol Head Neck Surg. 2023 Dec;75(4):3725-3732. doi: 10.1007/s12070-023-03912-0. Epub 2023 Jul 19.
10
Impact of dysplasia at resection margin on oncologic outcome after curative resection of oral tongue squamous cell carcinoma: significance of high-grade dysplastic resection margin.切除边缘不典型增生对口腔舌鳞癌根治性切除后肿瘤学结果的影响:高级别不典型增生切除边缘的意义。
Eur Arch Otorhinolaryngol. 2024 Jan;281(1):441-449. doi: 10.1007/s00405-023-08233-0. Epub 2023 Oct 4.